Nel ASA's Autumn Calendar Arrives With Little to Cheer the Sidelines

Nel ASA confirms reporting dates through Feb 2027, but no operational update; stock down 47% from May high amid CEO transition and widening losses.

Investors tracking Nel ASA now have their diaries sorted for the next 18 months, but the freshly published financial calendar does little to address the questions that have been weighing on the stock since early summer. The Norwegian hydrogen group confirmed its reporting dates for the remainder of 2026 and into 2027 — the third-quarter report lands on 21 October 2026, with the fourth-quarter and full-year figures following on 19 February 2027 — yet no operational update accompanied the schedule.

That absence of substance is becoming a familiar pattern. The share last traded at €0.1940, roughly 47 percent below the 52-week high of €0.3655 struck in May, and only about 12 percent above the February low of €0.1731. The 50-day moving average sits at €0.2023, leaving the current price about 4.1 percent beneath it — a technical signal that the near-term bias remains tilted downward, even if the recent drift has been more sideways than sharply bearish.

A CEO Exit That Complicates the Timeline

The calendar's release lands amid a leadership transition that has been open since mid-June, when Håkon Volldal stepped down as president and CEO. The picture sharpened considerably when Elopak, the Norwegian packaging group, confirmed that Volldal will take the helm there no later than 1 January 2027. That gives Nel's board a defined deadline to find a successor — a task made more pressing by the company's deteriorating financial trajectory.

The second-quarter numbers, published in July, continue to cast a long shadow. Revenue from customer contracts fell 12 percent year-on-year to 153 million Norwegian kroner, while the EBITDA loss widened to 155 million kroner from 86 million in the same period a year earlier. The net loss reached 189 million kroner, a figure that includes a one-off charge of 70 million kroner tied to a settlement with Iwatani Corporation of America, resolving litigation over a hydrogen refuelling station.

Cash reserves tell their own story: liquidity has contracted from 1.93 billion to 1.33 billion kroner over the past twelve months. There is a counterpoint in the order book, however — incoming orders climbed to 230 million kroner in the quarter, suggesting demand for electrolyser technology remains intact even as the income statement struggles.

Structural Demand Versus Operational Reality

That divergence between pipeline and performance is one reason Nel continues to appear in industry analyses. BCC Research recently listed the company among the significant global players in green hydrogen within a broader structure study of the energy and sustainability sector, citing accelerated investment driven by decarbonisation mandates and energy-security priorities. Nel has also been named as a central electrolyser supplier in connection with a South Korean memorandum of understanding for a 320-megawatt green hydrogen complex.

Yet these structural tailwinds have done little to move the needle on market sentiment. The stock has barely budged since the second-quarter release, and a JPMorgan price-target cut roughly three weeks ago also failed to generate much reaction. Automated rating services have turned cautious, a stance that aligns with the share's recent underperformance.

For investors, the October report now looms as the first genuine test of whether the new leadership — once appointed — can convert order momentum into revenue growth before the cash buffer erodes further. The calendar provides the framework for that reckoning, but the content remains very much in the company's hands.